AUM Biosciences to drive commercial innovation in oncology
Drug Discovery | News | 0 Comment | 25 Jun, 2018
Singapore - AUM Biosciences (AUM), a new company focused on the development of innovative and affordable oncology m...Read more
Mylan announces US launch of Bivalirudin for Injection
Drug Discovery | News | 0 Comment | 19 Jun, 2018
Global pharmaceutical company Mylan has announced the US launch of Bivalirudin for Injection, 250 mg singl...Read more
Ganovo approval marks a milestone for MAH policy in China
Drug Discovery | News | 0 Comment | 14 Jun, 2018
Ascletis (partner of WuXi STA) receives approval from National Drug Administration of China (CNDA, former CFDA) of its C...Read more
WuXi AppTec, Insilico unite to integrate AI with Drug Discovery
Drug Discovery | News | 0 Comment | 12 Jun, 2018
Insilico Medicine, a Baltimore-based next-generation artificial intelligence company specialized in the application of d...Read more
TESARO, Roche to evaluate triplet therapy for ovarian cancer
Drug Discovery | News | 0 Comment | 06 Jun, 2018
Singapore- TESARO, an oncology-focused biopharmaceutical company, announced that it has entered into a clinical co...Read more
USFDA grants Priority Review to Astellas's NDA for Gilteritinib
Drug Discovery | News | 0 Comment | 05 Jun, 2018
Japan’s Astellas Pharma recently announced that the U.S. Food and Drug Administration (FDA) has accepted, with Pri...Read more
Versartis, Aravive enter into merger agreement
Drug Discovery | News | 0 Comment | 04 Jun, 2018
Singapore- Versartis and Aravive Biologics jointly announced that they have entered into a definitive agreement under wh...Read more
Blueprint inks deal on oncology therapies with CStone
Drug Discovery | News | 0 Comment | 04 Jun, 2018
Singapore- Blueprint Medicines and CStone Pharmaceuticals, a privately-held biopharmaceutical company announce an e...Read more
Lilly and Incyte's drug gets FDA approval
Drug Discovery | News | 0 Comment | 04 Jun, 2018
Singapore- Eli Lilly and Company and Incyte Corporation announced that the U.S. Food and Drug Administration (FDA) has a...Read more
Amgen’s Biosimilar fails to get FDA approval
Drug Discovery | News | 0 Comment | 04 Jun, 2018
Singapore- Amgen, in a two-sentence announcement, said it received a complete response letter for the biosimilar of Roch...Read more
EC approves Roche’s Perjeta for HER2-positive early breast cancer
Drug Discovery | News | 0 Comment | 03 Jun, 2018
Global drug giant, Roche recently announced that the European Commission has approved Perjeta (pertuzumab) in combinatio...Read more
LUYE pharma Joins US Firm to Develop Immuno-oncology Treatments
Drug Discovery | News | 0 Comment | 29 May, 2018
LUYE PHARMA announced that the Group entered into a collaboration and license agreement with Elpis Biopharm, a Boston-re...Read more
FDA approves BioMarin’s metabolic disorder treatment
Drug Discovery | News | 0 Comment | 25 May, 2018
Singapore- U.S. regulators approved BioMarin Pharmaceutical Inc’s Palynziq for adults with phenylketonuria, a rare...Read more
Eisai, Merck provide Update on sNDA for Lenvatinib
Drug Discovery | News | 0 Comment | 25 May, 2018
Eisai Inc. and Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced that the U.S. Food and Dr...Read more
Celgene, Evotec team up on cancer treatments
Drug Discovery | News | 0 Comment | 22 May, 2018
Singapore- Celgene and German biotech Evotec AG have inked a long-term strategic drug discovery and development par...Read more
AstraZeneca submits sNDA for Forxiga in Japan
Drug Discovery | News | 0 Comment | 22 May, 2018
Global drug giant, AstraZeneca has submitted a supplemental new drug application (sNDA) to Japan’s Pharmaceuticals...Read more
Minerva’s drug shows treatment effect in schizophrenia patients
Drug Discovery | News | 0 Comment | 18 May, 2018
Singapore- Minerva Neurosciences, a clinical-stage biopharmaceutical company focused on the development of therapi...Read more
Cabometyx gets approval in Europe for first-line kidney cancer
Drug Discovery | News | 0 Comment | 18 May, 2018
Singapore- The European Commission (EC) has approved commercialization partner Ipsen's marketing application for C...Read more